AU1103701A - Glutamate transporter associated proteins and methods of use thereof - Google Patents

Glutamate transporter associated proteins and methods of use thereof

Info

Publication number
AU1103701A
AU1103701A AU11037/01A AU1103701A AU1103701A AU 1103701 A AU1103701 A AU 1103701A AU 11037/01 A AU11037/01 A AU 11037/01A AU 1103701 A AU1103701 A AU 1103701A AU 1103701 A AU1103701 A AU 1103701A
Authority
AU
Australia
Prior art keywords
methods
associated proteins
glutamate transporter
transporter associated
glutamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11037/01A
Inventor
Mandy Jackson
Robert Law
Glen Lin
Irina Orlov
Jeffrey D. Rothstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Medicine of Johns Hopkins University
Original Assignee
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by School of Medicine of Johns Hopkins University filed Critical School of Medicine of Johns Hopkins University
Publication of AU1103701A publication Critical patent/AU1103701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
AU11037/01A 1999-10-23 2000-10-23 Glutamate transporter associated proteins and methods of use thereof Abandoned AU1103701A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16100799P 1999-10-23 1999-10-23
US60161007 1999-10-23
US20615700P 2000-05-22 2000-05-22
US60206157 2000-05-22
PCT/US2000/029431 WO2001030968A2 (en) 1999-10-23 2000-10-23 Glutamate transporter associated proteins and methods of use thereof

Publications (1)

Publication Number Publication Date
AU1103701A true AU1103701A (en) 2001-05-08

Family

ID=26857429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11037/01A Abandoned AU1103701A (en) 1999-10-23 2000-10-23 Glutamate transporter associated proteins and methods of use thereof

Country Status (2)

Country Link
AU (1) AU1103701A (en)
WO (1) WO2001030968A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513675A1 (en) 2003-01-17 2004-08-05 The Johns Hopkins University Methods of identifying modulators of cellular glycosylation using gtrap3-18
CN103239710B (en) * 2013-05-14 2014-09-24 南京医科大学 Polypeptide with anti-tumor activity and application thereof
CN110669143B (en) * 2019-10-10 2021-05-14 中国人民解放军军事科学院军事医学研究院 Short peptide and application thereof
CN111467505A (en) * 2020-05-06 2020-07-31 南通大学 Application of glutamic acid transporter-1 gene transfected glial cells in treating traumatic brain injury
CN115536753A (en) * 2022-09-16 2022-12-30 苏州明人医药生物科技有限公司 Application of JWA polypeptide in preparation of drugs for resisting Parkinson's disease

Also Published As

Publication number Publication date
WO2001030968A2 (en) 2001-05-03
WO2001030968A3 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU6058500A (en) Fusion protein and uses thereof
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU6232300A (en) Receptors and associated proteins
AU5245900A (en) Novel protein and dna thereof
AU1103701A (en) Glutamate transporter associated proteins and methods of use thereof
EP1194548A4 (en) Novel pyrrhocoricin-derived peptides, and methods of use thereof
AU5907800A (en) Membrane-associated and secreted proteins and uses thereof
GB9918155D0 (en) Proteins and peptides
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU3207799A (en) Mpr-related abc transporter encoding nucleic acids and methods of use thereof
AU2136401A (en) P450rai-2 and related proteins
AU2136601A (en) Modified leukotoxin gene and protein
AU4927000A (en) Labelling of peptides and proteins
AU5634400A (en) Shank proteins and methods of use thereof
AU3411999A (en) Novel rnase-like protein and its use
AU5495500A (en) Decorin binding protein essential peptides and methods of use
AU2225401A (en) Novel protein and dna thereof
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU7756100A (en) Interleukin-2 like protein and nucleic acids encoding same
AU2567599A (en) Anti-ccr1 antibodies and methods of use therefor
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU2003292774A1 (en) Novel proteins and use thereof
AU2003280992A1 (en) Novel proteins and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase